U

A2i Therapeutics

Novel Small-molecule Immuno-oncology Agents
Startup Seed Founded 2020 Health Tech & Life Sciences
Last Update Nov 22, 2021

A2i Therapeutics News

1 article
Dec 20, 2020 · www.businesswire.com
Atomwise and FutuRx Launch A2i Therapeutics - A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority